Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Veracyte Inc shares valued at $57,802 were purchased by PHILLIP G FEBBO on Dec 04 ’24. At $44.09 per share, PHILLIP G FEBBO acquired 1,311 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Leite John sold 1,050 shares, netting a total of over 45,408 in proceeds. Following the sale of shares at $43.25 each, the insider now holds 73,810 shares.
Before that, Chambers Rebecca had sold 7,000 shares from its account. In a trade valued at $302,622, the Chief Financial Officer traded Veracyte Inc shares for $43.23 each. Upon closing the transaction, the insider’s holdings decreased to 7,000 shares, worth approximately $4.89 million.
As published in a research note from Goldman on December 05, 2024, Veracyte Inc [VCYT] has been rated down from a Buy to a Neutral and the price target has been revised to $37 from $38. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of October 16, 2024, UBS has initiated its “Buy” rating for VCYT. Earlier on October 10, 2024, Guggenheim initiated its rating. Their recommendation was “a Buy” for VCYT stock.
Analyzing VCYT Stock Performance
During the last five days, there has been a drop of approximately -0.12%. Over the course of the year, Veracyte Inc shares have jumped approximately 55.73%. Shares of the company reached a 52-week high of $44.50 on 12/04/24 and a 52-week low of $18.61 on 04/18/24. A 50-day SMA is recorded $36.31, while a 200-day SMA reached $27.11. Nevertheless, trading volume fell to 0.74 million shares from 0.47 million shares the previous day.
Support And Resistance Levels for Veracyte Inc (VCYT)
According to the 24-hour chart, there is a support level at 42.10, which, if violated, would cause prices to drop to 41.35. In the upper region, resistance lies at 43.49. The next price resistance is at 44.13. RSI (Relative Strength Index) is 65.08 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.53, which suggests the price will increase in the coming days. Percent R is at 18.18%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
